Cargando…

OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer

Insulin-like growth factor binding proteins (IGFBPs) are components of the IGF signaling system, which is comprised of ligands IGF-I and IGF-II as well as a family of transmembrane receptors including the IGF-IR and IGF-IIR. IGFBPs bind to both IGF-I and IGF-II with high affinity and are essential f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Qing, Harrell, J Chuck, Koblinski, Jennifer, Oh, Youngman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208346/ http://dx.doi.org/10.1210/jendso/bvaa046.1885

Ejemplares similares

IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
por: Cai, Qing, et al.
Publicado: (2020)

OR16-05 25-Hydroxycholesterol Mediates The Effects Of Dyslipidemia On Triple Negative Breast Cancer Metastasis
por: Etella, Abora, et al.
Publicado: (2023)

IGFBP-3 Inhibits Cytokine-Induced Insulin Resistance and Early Manifestations of Atherosclerosis
por: Mohanraj, Lathika, et al.
Publicado: (2013)

Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020)

OR05-02 Silencing Of Adenylosuccinate Lyase Impairs Growth And Perturbs Mitochondrial Function Of Endocrine Therapy Resistant Breast Cancer Cells
por: Yadav, Anil K, et al.
Publicado: (2023)

Increased Concentrations of Insulin-Like Growth Factor Binding Protein (IGFBP)-2, IGFBP-3, and IGFBP-4 Are Associated With Fetal Mortality in Pregnant Cows
por: Mense, Kirsten, et al.
Publicado: (2018)

IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
por: Honda, Makoto, et al.
Publicado: (2009)

Biochemical determinants of the IGFBP‐3–hyaluronan interaction
por: Dorandish, Sadaf, et al.
Publicado: (2020)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Alpha-1 Antitrypsin Inhibits Tumorigenesis and Progression of Colitis-Associated Colon Cancer through Suppression of Inflammatory Neutrophil-Activated Serine Proteases and IGFBP-3 Proteolysis
por: Cai, Qing, et al.
Publicado: (2022)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells
por: Igarashi, Ko, et al.
Publicado: (2020)

SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
por: Grible, Jacqueline M, et al.
Publicado: (2020)

Clinical significance of serum IGFBP‐3 in colorectal cancer
por: Hou, Yu‐Lei, et al.
Publicado: (2019)

SAT-137 The Effect of Hypertriglyceridemia on Triple Negative Breast Cancer Progression
por: Scully, Tiffany, et al.
Publicado: (2020)

Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study
por: Tamimi, Rulla M, et al.
Publicado: (2007)

Association study of IGFBP1 and IGFBP3 polymorphisms with hypertension and cardio-cerebral vascular diseases in a Chinese Han population
por: Fang, Zhengmei, et al.
Publicado: (2017)

SAT-139 STAT5A Regulation by Serine Phosphorylation in Breast Cancer
por: Woock, Alicia E, et al.
Publicado: (2020)

BIOL-08. IGFBP2 PROMOTES TUMOR METASTASIS IN SHH MEDULLOBLASTOMA
por: Kunhiraman, Haritha, et al.
Publicado: (2021)

Reduced Fragmentation of IGFBP-2 and IGFBP-3 as a Potential Mechanism for Decreased Ratio of IGF-II to IGFBPs in Cerebrospinal Fluid in Response to Repeated Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2021)

Triple Negative Breast Cancer is Dependent on the Lysosomal Cholesterol Transporter NPC1
por: O’Neill, Kathleen
Publicado: (2021)

IGFBP3 mRNA expression in benign and malignant breast tumors
por: Ren, Zefang, et al.
Publicado: (2007)

Correlation between Salivary Levels of IGF-1, IGFBP-3, IGF-1/IGFBP3 Ratio with Skeletal Maturity Using Hand-Wrist Radiographs
por: Almalki, Abdullah, et al.
Publicado: (2022)

SAT-145 Cholesterol Uptake as a Critical Vulnerability in Triple Negative Breast Cancer
por: O’Neill, Kathleen
Publicado: (2020)

THU489 The Role Of Noncoding Genes With The Bidirectional Promoter In Triple-negative Breast Cancer
por: Yang, Barbara, et al.
Publicado: (2023)

The IGF/Insulin-IGFBP Axis in Corneal Development, Wound Healing, and Disease
por: Stuard, Whitney L., et al.
Publicado: (2020)

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease
por: Takahashi, Shin-Ichiro, et al.
Publicado: (2022)

OR05-05 A Novel Model Of Prostate Cancer Suggests Enzalutamide Functions Through The Immune System To Diminish Castration Resistant And Metastatic Growth
por: Kregel, Steven
Publicado: (2023)

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
por: Watts, Eleanor L., et al.
Publicado: (2019)

Maternal high-protein diet modulates hepatic growth axis in weaning piglets by reprogramming the IGFBP-3 gene
por: Cong, Rihua, et al.
Publicado: (2019)

OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer
por: Duraki, Darjan, et al.
Publicado: (2020)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

SAT-151 Regulation of Low-Density Lipoprotein Receptor Expression in Triple Negative Breast Cancer
por: Scully, Tiffany, et al.
Publicado: (2020)

Nuclear ErbB-2-Induced Transcriptome Drives Triple Negative Breast Cancer Growth
por: Chervo, Maria F, et al.
Publicado: (2021)

IGFBP2 potentiates nuclear EGFR-STAT3 signaling
por: Chua, Corrine Yingxuan, et al.
Publicado: (2015)

IGFBP‐3 inhibits Wnt signaling in metastatic melanoma cells
por: Naspi, Antimo, et al.
Publicado: (2016)

IGFBP-1 and IGFBP-2 are associated with a decreased pulse-wave velocity in young, healthy adults
por: Pettersson-Pablo, Paul, et al.
Publicado: (2021)

OR05-04 Growth Hormone Receptor Antagonism Markedly Improves Therapeutic Response In Mouse Models Of Melanoma, Liver Cancer, Pancreatic Cancer And Cholangiocarcinoma
por: Basu, Reetobrata, et al.
Publicado: (2023)

Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
por: Lee, D. Y., et al.
Publicado: (1997)

Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR‐1184/IGFBP2 axis
por: Yang, Dengke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qlgv1ndfeqhotepiam79a5blom